Community Health selling four rural hospitals

Community Health Systems (CHS), one of the largest hospital chains in the U.S., has announced the sale of four rural hospitals as it tries to relieve some of its $15 billion debt.

The four hospitals being sold are the 95-bed Merit Health Gilmore Memorial in Amory, Mississippi; 112-bed Merit Health Batesville in Batesville, Mississippi; 181-bed Merit Health Northwest Mississippi in Clarksdale, Mississippi; and the 126-bed Highlands Regional Medical Center in Sebring, Florida.

“We are highly invested in the success of our affiliated hospitals, and we are considering how to best position them for the future,” said CHS Chairman and CEO Wayne T. Smith. “These four hospitals provide quality care and are important in each of their communities. They will benefit from alignment with a smaller organization specializing in the operation of rural hospitals. Divestiture of these assets advances our strategy to focus on a portfolio of larger hospitals and regional healthcare systems.”

The buyer is Clinton, Tennessee-based non-profit Curae Health. Curae currently operates three hospitals in Alabama, all acquired from LifePoint Health in 2015.

The terms of the deal weren’t disclosed, but CHS expects the transaction to close by the end of the year.

The company, which just two years ago was in a buying mode with its $7.6 billion purchase of Health Management Associates, had already shed 38 hospitals earlier this year by spinning them off into Quorom Health Corporation, raising around $1.2 billion. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.